España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glaxosmithkline, s.a. - antigeno superficie hepatitis b - excipientes: cloruro de sodio,dihidrogenofosfato de sodio dihidrato,hidrogenofosfato disodico dihidratado - vacunas antivirales - vacunas contra la hepatitis - hepatitis b, antígeno purificado de

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glaxosmithkline s.a. - antigeno superficie hepatitis b - suspensiÓn inyectable en jeringa precargada - n/a (vacuna) - n/a (vacuna) n/a (vacuna) - hepatitis b, antígeno purificado de

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glaxosmithkline s.a. - antigeno superficie hepatitis b - suspensiÓn inyectable en jeringa precargada - n/a (vacuna) - n/a (vacuna) n/a (vacuna) - hepatitis b, antígeno purificado de

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

glaxosmithkline s.a. - antigeno superficie hepatitis b - suspensiÓn inyectable - n/a (vacuna) - antigeno superficie hepatitis b n/a (vacuna) n/a (vacuna) - hepatitis b, antígeno purificado de

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hepatitis b surface antigen, recombinant 20 µg/ml; hepatitis b surface antigen, recombinant 20 µg/ml - suspension for injection - 10 mcg/0.5ml - active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate phenoxyethanol sodium chloride thiomersal water for injection active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate sodium chloride water for injection - engerix-b is indicated for active immunization against hepatitis b virus infection.

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hepatitis b surface antigen, recombinant 20 µg/ml; hepatitis b surface antigen, recombinant 20 µg/ml - suspension for injection - 20 mcg/ml - active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate phenoxyethanol sodium chloride thiomersal water for injection active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate sodium chloride water for injection - engerix-b is indicated for active immunization against hepatitis b virus infection.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis b surface antigen recombinant, quantity: 10 microgram - injection, suspension - excipient ingredients: water for injections; aluminium hydroxide hydrate; dibasic sodium phosphate dihydrate; sodium chloride; monobasic sodium phosphate - engerix-b is indicated for active immunisation against hepatitis b virus infection. the nh&mrc* recommend all infants, young children and unvaccinated adolescents receive a primary course of immunisation against hepatitis b. the nh&mrc also recommends immunisation for persons who are at substantial risk and have been demonstrated or judged to be susceptible to the hepatitis b virus. groups identified at increased risk of acquiring hbv infection include: infants born to carrier (hbsag-positive) mothers; individuals for whom post-exposure prophylaxis for hepatitis b is indicated; household contacts (other than sexual partners) of acute and chronic hepatitis b cases and carriers; susceptible sexual contacts. risk occurs in susceptible (anti-hbs negative) partners of hbv carriers and patients with acute hepatitis b; susceptible clients of std (sexually transmitted disease) clinics, and sexually active men who have sex with men are also at increased risk of infection; injecting drug users; haemodialysis patients,

Australia - inglés - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis b surface antigen recombinant, quantity: 20 microgram/ml - injection, suspension - excipient ingredients: monobasic sodium phosphate; aluminium hydroxide hydrate; water for injections; sodium chloride; dibasic sodium phosphate dihydrate - engerix-b is indicated for active immunisation against hepatitis b virus infection. the nh&mrc* recommend all infants, young children and unvaccinated adolescents receive a primary course of immunisation against hepatitis b. the nh&mrc also recommends immunisation for persons who are at substantial risk and have been demonstrated or judged to be susceptible to the hepatitis b virus. groups identified at increased risk of acquiring hbv infection include: infants born to carrier (hbsag-positive) mothers; individuals for whom post-exposure prophylaxis for hepatitis b is indicated; household contacts (other than sexual partners) of acute and chronic hepatitis b cases and carriers; susceptible sexual contacts. risk occurs in susceptible (anti-hbs negative) partners of hbv carriers and patients with acute hepatitis b; susceptible clients of std (sexually transmitted disease) clinics, and sexually active men who have sex with men are also at increased risk of infection; injecting drug users; haemodialysis patients,

Francia - francés - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

laboratoire glaxosmithkline - antigène de surface de l'hépatite b recombinant - suspension - 20,000 microgrammes - composition pour 1 dose de 1 ml > antigène de surface de l'hépatite b recombinant : 20,000 microgrammes - engerix b, vaccin contre l'hépatite b, est une suspension stérile contenant le principal antigène de surface purifié du virus, produit par la technologie de l'adn recombinant, adsorbé sur de l'hydroxyde d'aluminium hydraté.

Francia - francés - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

laboratoire glaxosmithkline - antigène de surface de l'hépatite b recombinant - suspension - 10 microgrammes - composition pour une dose de 0,5 ml > antigène de surface de l'hépatite b recombinant : 10 microgrammes - engerix b, vaccin contre l’hépatite b, est une suspension stérile contenant le principal antigène de surface purifié du virus, produit par la technologie de l’adn recombinant, adsorbé sur de l’hydroxyde d’aluminium hydraté.